Publications by authors named "S Demeyer"

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological disease originating from the malignant transformation of T-cell progenitors, caused by the accumulation of genetic aberrations. One-fifth of T-ALL patients are characterized by ectopic expression of the homeobox transcription factor TLX3. However, the role of TLX3 in T-ALL remains elusive, partly due to the lack of suitable study models.

View Article and Find Full Text PDF

Acute lymphoblastic leukemia (ALL) is the most common cancer in children. ALL originates from precursor lymphocytes that acquire multiple genomic changes over time, including chromosomal rearrangements and point mutations. While a large variety of genomic defects was identified and characterized in ALL over the past 30 years, it was only in recent years that the clonal heterogeneity was recognized.

View Article and Find Full Text PDF

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive type of leukemia caused by accumulation of multiple genetic alterations in T-cell progenitors. However, for many genes it remains unknown how their mutations contribute to disease development. We therefore performed two single-cell CRISPR screens in primary pro-T cells ex vivo to study the transcriptional impact of loss-of-function alterations in T-ALL and correlate this with effects on cell fitness.

View Article and Find Full Text PDF

Background: Lymphangiogenesis, the formation of lymphatic vessels, is tightly linked to the development of the venous vasculature, both at the cellular and molecular levels. Here, we identify a novel role for Sorbs1, the founding member of the SoHo family of cytoskeleton adaptor proteins, in vascular and lymphatic development in the zebrafish.

Results: We show that Sorbs1 is required for secondary sprouting and emergence of several vascular structures specifically derived from the axial vein.

View Article and Find Full Text PDF
Article Synopsis
  • Plasmodium parasites cause malaria, leading to over 200 million cases and 600,000 deaths annually, with complications like malaria-associated acute respiratory distress syndrome (MA-ARDS) contributing significantly to mortality despite effective antimalarial drugs.* -
  • A study on infected mice showed that treatment with antimalarial drugs post-symptom onset resulted in 80% survival, while alterations in lung function and inflammation were observed during infection and recovery.* -
  • The research highlights important changes in inflammatory pathways and endothelial cell behavior during the resolution phase of MA-ARDS, suggesting potential new therapeutic strategies to enhance recovery after parasite elimination.*
View Article and Find Full Text PDF